Clovertex’s May Target of the Month is B-Raf, a serine/threonine kinase that plays a central role in...
Bitter days for the industry, sweet days for cryo-EM. This month’s SBDD social pulse captures a stri...
Clovertex’s April 2025 Target of the Month is the neonatal Fc receptor (FcRn), following the U.S. FD...
April delivered no shortage of turbulence — but also a few genuine bright spots. Amid ongoing instab...
Clovertex’s March Target of the Month is GSPT1, a translation termination factor that plays a vital ...
This month, Cryo-EM provided new insights into the vitamin K enzyme, as well as channel and GPCR str...
Clovertex's February Target of the Month is the farnesoid X receptor (FXR), a nuclear receptor that ...
Submit your research abstracts for the upcoming Proteros-sponsored International Biostructure Associ...
In the world of structural biology, few tools have had as profound an impact as scFv16. This single-...
This month’s top posts, grouped by platform (Bluesky, X, and LinkedIn), showcase the latest cryo-EM ...